IN8bio, Inc.
IN8bio, Inc.:
IN8bio focuses on developing allogeneic, autologous and genetically modified gamma-delta T cells therapies for cancer treatments using its DeltEx Platform, based on ex-vivo expanded and activated gamma-delta T cells. First company to advance modified gamma-delta T cells into clinical trials. IN8bio has completed first cohort dosing for its two investigator-initiated Phase 1 clinical trials INB-200 for the treatment of newly diagnosed glioblastoma, which is a difficult to treat brain tumor that progresses rapidly, and INB-100 for the treatment of patients with acute leukemia undergoing hematopoietic stem cell transplantation.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Middle Atlantic
Clinical Stage
Phase l or ll
Disease Space
Oncology
Listing
Public, USA
Market Cap
<100MM
Therapeutic Modalities
Cell Therapy, Gene Therapy
Website:
Address:
79 Madison Ave.
New York, NY 10016
United States
New York, NY 10016
United States
More info:
My account:
Company Participants at Solebury Trout 1x1 Management Access Event 2022
- Charles Butler, Vice President, Corporate Communications & Investor Relations
- William T. Ho, President/CEO/Co-Founder
Top 10 Holders of IN8bio, Inc.
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Capital Research & Management Co. (World Investors) | 4.27 | 800,000 | 1.75 | 13F | 3/31/22 |
| Nantahala Capital Management LLC | 1.88 | 352,753 | 0.77 | 13F | 3/31/22 |
| Voss Capital LLC | 1.38 | 259,003 | 0.57 | 13F | 3/31/22 |
| B. Riley Financial, Inc. | 1.37 | 257,513 | 0.56 | 13F | 3/31/22 |
| The Vanguard Group, Inc. | 0.60 | 113,604 | 0.25 | Funds | 4/30/22 |
| Vanguard Group, Inc. (Subfiler) | 0.59 | 110,662 | 0.24 | 13F | 3/31/22 |
| Sigma Planning Corp. | 0.52 | 97,750 | 0.21 | 13F | 3/31/22 |
| The Rock Creek Group LP | 0.46 | 86,032 | 0.19 | 13F | 3/31/22 |
| Ensign Peak Advisors, Inc. | 0.37 | 70,028 | 0.15 | 13F | 3/31/22 |
| Bridgeway Capital Management LLC | 0.32 | 60,000 | 0.13 | 13F | 3/31/22 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.